Grannus Therapeutics

About:

Grannus Therapeutics is a biotechnology company that focuses on the development of small molecule inhibitors for specific isoforms of HSP90.

Top Investors: Elevate Ventures

Description:

Grannus Therapeutics is a biotechnology company that focuses on the development of small-molecule inhibitors for specific isoforms of HSP90. The company was founded in 2020 and is headquartered in Indianapolis, Indiana.

Total Funding Amount:

$1.75M

Headquarters Location:

Indianapolis, Indiana, United States

Founded Date:

2020-01-01

Founders:

John Foglesong, Sanket Mishra

Number of Employees:

1-10

Last Funding Date:

2024-01-11

IPO Status:

Private

Industries: